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What are interesterified fats and should we
be worried about them in our diet?
C. E. Mills, W. L. Hall and S. E. E. Berry
King’s College London, London, UK
Abstract Interesterified (IE) fats are used in a wide range of food products and were
introduced as a replacement for trans fats, which are known to be detrimental to
cardiovascular health. However, the effects of interesterification on metabolism
and subsequent effects on cardiovascular health are not understood and previous
studies have seldom investigated industrially-relevant IE fats. No legislation
currently exists regarding the labelling of IE fats in food products and therefore
estimates of average consumption rates in the UK population are currently
unavailable. In order to meet the urgent need for a systematic investigation of the
health effects of consumer-relevant IE fats, it is essential to estimate current IE
fat intakes and to investigate biological mechanisms that might mediate acute
and chronic cardiometabolic effects of commercially relevant IE fats.
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Introduction
This article reviews the background and current
knowledge forming the rationale for the new
Biotechnology and Biological Sciences Research
Council Diet and Health Research Industry Club
(BBSRC-DRINC)-funded project on the health
impact of interesterified fat.
Cardiovascular disease (CVD) remains one of the big-
gest public health concerns globally and there is sub-
stantial evidence that following dietary guidelines on
dietary fatty acid intakes may reduce risk of CVD
events (Oh et al. 2005; Toledo et al. 2013; Reidlinger
et al. 2015). Much research and discussion have been
devoted to the strength of the evidence for the health
benefits of replacing saturated fatty acids with
unsaturated fatty acids and the role of reducing dietary
trans fatty acids in lowering CVD risk, which is well
established (Mozaffarian et al. 2006). Artificial trans
fats (generated from vegetable oils that have under-
gone partial hydrogenation to turn them into solid or
semi-solid fats) were originally introduced as a cheaper
and healthier alternative to animal fats. However,
levels of artificial trans fat in the UK diet have reduced
markedly as UK food manufacturers have moved away
from using these as a source of hard vegetable fat in
their products (Stender et al. 2014). Interesterified (IE)
fats are now used as a hard fat replacement for trans
fats in a large range of commonly consumed foods,
including spreads, bakery and confectionary products.
Similar to artificially produced trans fats, there is no
legal requirement for food manufacturers to include IE
fats on food labels. Thus, without collaboration from
the food industry, it is hard to approximate how much
is being consumed. Estimates from US data suggest
that approximately 3% of energy intake would come
from IE fats if they were the sole replacement hard fat
for partially hydrogenated vegetable oil (Lefevre et al.
2012). The drive for a reduction in industrial trans
fats in food products was prompted by evidence
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indicating associations between consumption and
undesirable cardiovascular health effects (Mozaffarian
et al. 2006). IE fats were introduced as a suitable
replacement as they can provide desirable functional
properties, related to the product’s melting point, tex-
ture and shelf stability. Without such fats, these prod-
ucts would need to be made from high-saturated fat
products, such as butter or lard, otherwise they would
have very different textural characteristics; consider the
textural and stability challenges in manufacturing bis-
cuits made from rapeseed oil – a softer, less shelf-stable
product would result.
Despite IE fat being widely used in food products in
the UK and worldwide for decades, the impact on car-
diovascular health is unknown. The use of IE fats
instead of animal fats is assumed to be beneficial as it
should help meet the population target for saturated
fatty acids intake of <11% daily energy intake
(Department of Health 1991), but there has been no
systematic attempt to establish whether this is the
case. With the relatively recent reformulation of prod-
ucts containing trans fat, it is important for industry
to be confident in the fat replacements that they are
using and, therefore, research in this area is a matter
of priority. Available research to date has not assessed
the health effects of the type of IE fats that are used in
UK food products. Herein, we will discuss current
understanding of IE fat metabolism and its impact on
cardiovascular health. We will also present our new
research project, which will engage major food indus-
try stakeholders in knowledge exchange partnerships
to identify the most industrially relevant IE fats.
Finally, we will consider future priority areas of
research in this field.
What are interesterified fats and why does
the food industry use them?
What? Dietary fats consist predominantly of triacylglyc-
erols (TAG) (~95% of dietary fat), which are formed
of three fatty acids esterified to a glycerol backbone.
Fatty acids are positioned in one of three places on the
glycerol molecule and labelled using a stereospecific
numbering system (sn); sn-1 and sn-3 refer to the fatty
acids on the outer positions and sn-2 is the fatty acid in
the middle (Gurr et al. 2016) (Fig. 1).
The nature of the fatty acids within the TAG deter-
mines the physical and (bio)chemical properties of the
TAG; for example, the length of the fatty acid chains,
level of unsaturation and, if unsaturated, the position
(e.g. n-3, n-6, n-9), and geometry of the double bonds
(cis or trans). Interesterification is the process of
swapping or rearranging fatty acids within a TAG
(between the sn-1, 2 and 3 positions) or between TAGs,
by either chemical (giving random esterification, where
fatty acids are moved to unspecified positions) or
enzymic (which can give random or directed esterifica-
tion, where fatty acids can be moved to specific posi-
tions) means. Figure 2 shows a simplified schematic of
random (A) and direct interesterification (B). This
reshuffling of fatty acids produces different TAG
molecular species and can be used to create fats with
either a specific positional composition (e.g. Betapol,
an infant formula product, which mimics the posi-
tional composition of human breastmilk) or physical
properties (e.g. modifying the melting point and solid
fat content, without increasing the levels of saturated
fatty acids). The commercial interesterification process
used by the food industry for spreads, bakery and con-
fectionary products reduces the saturated fatty acid
content of the fat by approximately 10% compared to
a non-IE fat with a similar solid content. In Europe,
palmitic acid-based fats are commonly interesterified
using combinations of palm oil fractions (palm kernel
and palm stearin) to generate an IE hard stock. This
IE hard stock is then blended at different ratios
(depending on the final application and required solid fat
content) with a vegetable oil, such as rapeseed or lin-
seed oil. Plant and animal fats have different structural
compositions as can be seen in Table 1 (Small 1991;
Berry 2009). Plant fats typically have higher propor-
tions of saturated fatty acids at sn-1 and sn-3, whereas
animal fats have higher proportions of saturated fatty
acids at sn-2. Hence, industrial interesterification of
plant fats will often yield TAGs with increased pro-
portions of saturated fatty acids at the sn-2 position as
well as modifying the melting properties of the fat.
Why? The UK government has long recommended
that saturated fatty acids in the diet should be reduced
(Department of Health 1991). In a bid to reduce high-
Figure 1 Triacylglycerol (TAG) structure showing glycerol with three fatty
acids.
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saturated fat foods, the food industry has historically
utilised structural geometry changes in partially hydro-
genated vegetable oil to create trans fatty acids, which
increases the melting point of the vegetable oil. Par-
tially hydrogenated vegetable oils are shelf-stable, have
a high solid fat content and replicate the physical
properties of high melting point saturated fats. How-
ever, high trans fatty acid content has since been
shown to be detrimental to cardiovascular health; for
example, a recent meta-analysis showed associations
between consumption of trans fat and both total and
coronary heart disease mortality (relative risk 1.21
and 1.28, respectively). This was found to be specifi-
cally related to industrially produced (or artificial)
trans fatty acids, rather than the natural (i.e. rumi-
nant) trans fatty acids (de Souza et al. 2015).
Blending fats, fractionation, full hydrogenation
(which does not yield trans fatty acids), interesterifica-
tion or genetic modification are all viable alternatives
to trans fat. However, none of these processes alone
produce fats with suitable functionality for most of
the food applications required and the combined pro-
cess of interesterification of blends of fractionated fats
or fully hydrogenated fats appears to be the best
option available for the food industry. In the UK,
there is currently a legal requirement for clear label-
ling of hydrogenated fats in food products. However,
labelling does not distinguish between fully or par-
tially hydrogenated fats. Therefore, consumers do not
differentiate between fully hydrogenated and partially
hydrogenated (trans) fat and simply deem hydro-
genated fats as ‘bad fats’. Consequently, the UK food
industry has been driven away from using full hydro-
genation as consumers avoid it. Therefore, IE fraction-
ated fats are the most commonly used method by the
UK food industry.
Estimating intake of interesterified fat
It is difficult to accurately estimate intakes of IE fat in
the UK population as there is no requirement for IE
fats to be labelled on food products and analysis of
the IE content in foods is a complex, technically chal-
lenging process. To date, no estimations of dietary IE
fat intake in the UK have been made. Lefevre et al.
(2012) modelled data from the National Health and
Nutrition Examination Survey (NHANES) to predict
intake of IE fully hydrogenated soya bean oil (a stearic
acid-rich IE fat) in the US if used as a (application
appropriate) replacement hard fat for trans fats. They
estimated that IE fat intakes in the NHANES popula-
tion would be approximately 3% of daily energy
(Lefevre et al. 2012). They also predicted that replac-
ing trans fats with a fully hydrogenated stearic acid-
rich IE fat would reduce CVD risk by 1.2%. How-
ever, since these results were based on stearic acid-rich
IE fat, they cannot be extrapolated to the UK popula-
tion, as in the UK trans fats have already been
replaced with palmitic acid-rich IE fats (Lefevre et al.
2012).
In the light of this, there is a pressing need to esti-
mate the amount of IE fat consumed in the UK, based
on the main IE fat blends used by the food industry,
in order to assess the potential public health effects of
their use in place of other application appropriate fats.
To estimate UK intakes of IE fat, a similar approach
to that taken by Lefevre et al. (2012) would need to
be applied to the National Diet and Nutrition Survey
(NDNS) population data. Such estimates would
inform the design of clinical trials to test the health
effects of IE fat; this is an area that our group are cur-
rently working on as part of a recently awarded
BBSRC-DRINC grant, as discussed below.
Figure 2 Simpliﬁed schematic representing random (A) and directed (B)
interesteriﬁcation of palmitoyl-oleoyl-palmitoylglycerol (palmitic, oleic, palmi-
tic acids; POP) and stearoyl-oleoyl-stearoylglycerol (stearic, oleic, stearic
acids; SOS)
Table 1 Details of abundant triacylglycerol molecular species in
various foods
% total fat saturated Major triacylglycerols *
Breastmilk 44 OPO, OPP
Betapol (formula milk) 44 OPO
Cow’s milk 50 POO, PPO, OPO
Butter 63 PPB, PPC, POP
Lard 44 SPO, OPL, OPO
Palm oil 49 POP, POO, POL
Rapeseed oil 7 OOO, LOO, OOLn
Linseed oil 9 LnLnLn, LnLnL, LnLnO
B is butyric acid, 4:0; C is capric acid, 10:0; L is linoleic acid, 18:2, Ln is lino-
lenic acid, 18:3; O is oleic acid, 18:1; P is palmitic acid, 16:0; S is stearic acid,
18:0 [Sources: Berry (2009); Small (1991)]
*Written as sn-1 sn-2 sn-3
© 2017 The Authors. Nutrition Bulletin published by John Wiley & Sons Ltd on behalf of British Nutrition Foundation Nutrition Bulletin, 42, 153–158
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Does interesterification of palmitic acid-rich
fats influence their digestion, lipid
metabolism or impact on cardiovascular
health?
The impact of fat consumption on health, particularly
cardiovascular health, is a topic that is regularly under
debate. Although there is general consensus regarding
the effect of degree of saturation and molecular geom-
etry of fats on cardiovascular health, the influence of
the specific arrangement of the fatty acids on the glyc-
erol backbone on lipid metabolism and cardiovascular
physiology is not understood. As with molecular
geometry, there is a possibility that positional compo-
sition may affect dietary fat metabolism, digestibility
and subsequent effects on cardiovascular health [as
discussed in depth previously by our group (Berry
2009)]; however, the data are not consistent nor com-
plete, with most studies using fats which are not com-
mercially relevant.
Historically, it was believed that animal fats were
more atherogenic than plant fats due to their posi-
tional composition (e.g. a higher proportion of satu-
rated fatty acids in the sn-2 position), despite, in
some incidences, having a similar saturated fatty acid
content (e.g. palm oil and lard; see Table 1). A plau-
sible explanation for this is differences in digestion
due to the specificity of pancreatic and lipoprotein
lipase. These enzymes preferentially hydrolyse fatty
acids at the sn-1 and sn-3 positions of TAG, which
are released as free fatty acids, leaving a 2-monoacyl-
glycerol (2-MAG: glycerol backbone with saturated
fatty acid at sn-2) (Nilsson-Ehle et al. 1973; Yang &
Kuksis 1991). Animal and human infant studies show
that high melting point saturated fatty acids (such as
stearic and palmitic acids) are poorly absorbed as
free fatty acids compared to when they are present
as 2-MAG. Therefore, it has been suggested that
industrial interesterification of plant fats (which
increases the proportion of saturated fatty acids in
the sn-2 position, see Fig. 2) may improve the
absorption/digestibility of saturated fatty acids.
Indeed, this has been demonstrated in animals
(Tomarelli et al. 1968; Mattson et al. 1979) and
human infants (Filer et al. 1969; Carnielli et al.
1995), which suggests that saturated fatty acids con-
sumed in products containing industrially IE fats are
better digested, absorbed and cleared more quickly
from circulation than those which contain saturated
fatty acids at sn-1 or sn-3. This could have addi-
tional implications for health as these saturated fatty
acids containing 2-MAG may cause downstream
effects due to differential incorporation into phospho-
lipids, or differential delivery to the liver and periph-
eral tissues. However, animals lack, and human
infants have low levels of, pancreatic and lipoprotein
lipases, which will have an impact on the digestion
and subsequent absorption and metabolism of TAG.
Indeed, human adult studies demonstrate that satu-
rated fatty acids are well absorbed regardless of their
position (Shahkhalili et al. 2000) and that position
does not differentially influence rates of metabolism
(Summers et al. 1998, 1999). There are insufficient
data to draw sound conclusions regarding the effect
of IE fat on metabolism and digestibility in humans,
specifically those used commercially in the UK and
Europe.
Although it is important to consider the long-term
health effects of dietary fats, assessing acute
responses provides insight into whether there is likely
to be an impact on lipoprotein metabolism which
underpins many of the chronic cardiometabolic
effects of dietary fat (Jackson et al. 2012). The dura-
tion and peak of postprandial lipaemia, a physiologi-
cal response to fat-containing meals that is
characterised by a rise in blood TAG concentrations
2–8 hours after a meal, are considered independent
markers of CVD risk. Similar to the research on
metabolism and digestibility, there is little consensus
on the impact of IE fats on postprandial lipaemia.
Most studies have observed a reduction (Yli-Jokipii
et al. 2001; Berry & Sanders 2003; Sanders et al.
2003) or no change (Zampelas et al. 1994; Summers
et al. 1998, 1999; Yli-Jokipii et al. 2003; Berry et al.
2007a,b) in postprandial lipaemia in response to IE
fats. However, these studies used IE fats that are
rarely used by the UK food industry. Using the most
commonly consumed IE palmitic acid-rich fat, our
group recently reported that an IE palm kernel/palm
stearin hard stock (80:20 blend) increased postpran-
dial lipaemia compared to the non-IE equivalent fat;
see Figure 3 (Hall et al. 2016); this is contrary to all
previous studies using commercially irrelevant IE fats.
However, this pilot study assessed postprandial
effects for only 4 hours and longer term postprandial
effects need to be characterised, as both the duration
and the peak lipaemic response are important in
influencing CVD risk factors.
Ongoing research and future directions
Commercial IE fats may make a significant contribu-
tion to the UK diet, but evidence to date on the car-
diovascular health effects of IE fats is largely based on
© 2017 The Authors. Nutrition Bulletin published by John Wiley & Sons Ltd on behalf of British Nutrition Foundation Nutrition Bulletin, 42, 153–158
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studies using IE fats that are not used commercially.
Therefore, there is an urgent need to systematically
investigate the estimated intakes and health effects of
food industry-relevant IE fats. Areas of uncertainty
that should be addressed include mechanisms deter-
mining the postprandial handling of IE fats, acute and
chronic cardiometabolic effects of commercially rele-
vant IE fats at relevant doses and the differences
between the cardiovascular health effects of stearic
acid- and palmitic acid-rich IE fats.
Preliminary research from our group found that one
of the most commonly consumed IE fat blends when
incorporated into high-fat test meals led to increased
blood TAG concentrations up to 4 hours post-
consumption, compared to the equivalent non-IE fat
(Hall et al. 2016). Large rises in blood lipids after
meals are an important risk factor for CVD. Our new
BBSRC-DRINC grant ‘The health impact of industrial
interesterification of dietary fat’ will investigate the
cardiometabolic health effects of the most widely con-
sumed IE fats to explore our initial findings in more
detail. The project will be run at the Division of Dia-
betes and Nutritional Sciences at King’s College Lon-
don and is organised into three work packages. Work
package 1 will estimate the dietary intake of IE fat in
the UK using an existing database of dietary intakes
(NDNS, years 2013-2014), which encompasses a
large, nationally representative study population, in
combination with information on IE fat contents of
foods provided by industry. This information will be
used to predict the likely impact on blood lipid pro-
files if current dietary intakes of IE fats were replaced
by traditional hard fats, such as butter and lard. This
will provide the first ever data on the potential public
health impact of including these fats in the UK food
supply. Work package 2 will involve a detailed human
study to assess the digestion, absorption and metabo-
lism of the most commonly consumed IE fat, com-
pared to the non-IE equivalent fat. Work package 3
will include a second human study to determine
whether blends of different proportions of IE fats (i.e.
the proportions that are most commonly consumed in
products such as ‘healthier’ spreads and bakery fats)
have any effects on markers of cardiometabolic risk
[such as postprandial lipaemia, flow mediated dilata-
tion (FMD), nitric oxide bioavailability], compared to
control oils/fats containing 0 and 100% IE fat.
This work will provide a better understanding of
the potential cardiovascular health impact of current
intakes of IE fat and will form the basis of much
needed chronic dietary intervention trials designed to
explore the effects of IE fats on public health.
Scientific evidence on the potential health effects of
consuming IE fats will be particularly relevant to the
food industry, nutritionists, dietitians, other health pro-
fessionals and government policymakers and may even-
tually be translated into national dietary guidelines.
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